Search results for: 'signaling pathways cardiovascular {{media url='
- R1007 ARCA EGFP mRNA (5-moUTP)Summary: New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.
- R1005 Firefly Luciferase mRNA (ARCA, 5mCTP, ψUTP)Summary: Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
- R1012 Firefly Luciferase mRNA (ARCA, 5-moUTP)Summary: Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
- R1013 EZ Cap™ Firefly Luciferase mRNA (5-moUTP)Summary: Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1015 EZ Cap™ Cas9 mRNA (5-moUTP)Summary: Used with guideRNA for site-specific DNA cleavage in genome editing.
- R1018 EZ Cap™ Firefly Luciferase mRNASummary: Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
- R1016 EZ Cap™ EGFP mRNA (5-moUTP)Summary: EGFP mRNA with Cap 1 structure, modified by 5-moUTP,providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1057 EZ Cap™ Human IL-12 mRNA (m1Ψ,HA tag)Summary: Human IL-12 mRNA with Cap 1 structure and HA tag sequence., modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1058 EZ Cap™ Mouse IL-12 mRNA (m1Ψ)Summary: Mouse IL-12 mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1050 EZ Cap™ Mouse IFN-α mRNA (m1ψ)Summary: Mouse IFN-α mRNA with Cap 1 structure, modified by m1ψ, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation